Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835
Books209
All textbooksMedical textbooksHuman anatomyOrganisms & biodiversityOther sciences
Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›Open textbooks›Improving the Effectiveness of Psychological Interventions for Depression and Anxiety in Cardiac Rehabilitation: The PATHWAY Research Programme Including 4 RCTs›References

Continue where you left off ()

GO BEYOND THE PAGEReading is just the beginning.

Turn scientific reading into research. Compare studies, examine evidence, and organize your findings in EvidenceHelix Workspace.

Explore Research Workspace →

Improving the Effectiveness of Psychological Interventions for Depression and Anxiety in Cardiac Rehabilitation: The PATHWAY Research Programme Including 4 RCTs · References

References

CC BY 4.0 · National Institute for Health and Care Research · approximately 8 min read

  1. British Heart Foundation (BHF). BHF UK Factsheet 2021. British Heart Foundation; 2021. URL: www.bhf.org.uk/what-we-do/our-research/heart-statistics/heart-statistics-publications (accessed 14 December 2021).
  2. British Association for Cardiovascular Prevention and Rehabilitation (BACPR). The BACPR Standards and Core Components for Cardiovascular Disease Prevention and Rehabilitation 2017, 3rd Edition. BACPR; 2017. URL: www.bacpr.com/resources/AC6_BACPRStandards&CoreComponents2017.pdf (accessed 14 December 2021).
  3. Shields G, Wells A, Doherty P, Heagerty A, Buck D, Davies L. Cost-effectiveness of cardiac rehabilitation: a systematic review. Heart 2018;104:1403–10. 10.1136/heartjnl-2017-31280929654096
  4. Anderson L, Oldridge N, Thompson D, Zwisler A, Rees K, Martin N, et al. Exercise-based cardiac rehabilitation for coronary heart disease. J Am Coll Cardiol 2016;67:1–12. 10.1016/j.jacc.2015.10.04426764059
  5. National Audit of Cardiac Rehabilitation. National Audit of Cardiac Rehabilitation Annual Report 2019. York: British Heart Foundation, University of York; 2019. URL: www.bhf.org.uk/informationsupport/publications/statistics/national-audit-of-cardiac-rehabilitation-quality-and-outcomes-report-2019 (accessed 14 December 2021).
  6. Palacios J, Khondoker M, Mann A, Tylee A, Hotopf M. Depression, and anxiety symptom trajectories in coronary heart disease: associations with measures of disability and impact on 3-year health care costs. J Psychosom Res 2018;104:1–8. 10.1016/j.jpsychores.2017.10.01529275777
  7. Richards S, Anderson L, Jenkinson C, Whalley B, Rees K, Davies P, et al. Psychological interventions for coronary heart disease. Cochrane Database Syst Rev 2017;4. 10.1002/14651858.CD002902.pub4
  8. Wells A. Metacognitive Therapy for Anxiety and Depression. New York, NY: Guilford Press; 2009.
  9. Normann N, van Emmerik AA, Morina N. The efficacy of metacognitive therapy for anxiety and depression: a meta-analytic review. Depress Anxiety 2014;31:402–11. 10.1002/da.22273 PMID: 24756930.24756930
  10. Callesen P, Reeves D, Heal C, Wells A. Metacognitive therapy versus cognitive behaviour therapy in adults with major depression: a parallel single-blind randomised trial. Sci Rep 2020;10:7878. 10.1038/s41598-020-64577-132398710
  11. Nordahl HM, Borkovec TD, Hagen R, Kennair LEO, Hjemdal O, Solem S, et al. Metacognitive therapy versus cognitive-behavioural therapy in adults with generalised anxiety disorder. BJPsych Open 2018;4:393–400. 10.1192/bjo.2018.54 PMID: 30294448; PMCID: PMC6171331.30294448
  12. Wells A, Walton D, Lovell K, Proctor D. Metacognitive therapy versus prolonged exposure in adults with chronic post-traumatic stress disorder: a parallel randomized controlled trial. Cognit Ther Res 2015;39:70–80. 10.1007/s10608-014-9636-6
  13. Normann N, Morina N. The efficacy of metacognitive therapy: a systematic review and meta-analysis. Front Psychol 2018;9:2211. 10.3389/fpsyg.2018.0221130487770
  14. McPhillips R, Salmon P, Wells A, Fisher P. Cardiac rehabilitation patients’ accounts of their emotional distress and psychological needs: a qualitative study. J Am Heart Assoc 2019;8:e011117. 10.1161/JAHA.118.01111731433708
  15. McPhillips R, Salmon P, Wells A, Fisher P. Qualitative analysis of emotional distress in cardiac patients from the perspectives of cognitive behavioral and metacognitive theories: why might cognitive behavioral therapy have limited benefit, and might metacognitive therapy be more effective? Front Psychol 2019;9:2288. 10.3389/fpsyg.2018.0228830662413
  16. Wells A, Reeves D, Heal C, Fisher P, Davies L, Heagerty A, et al. Establishing the feasibility of group metacognitive therapy for anxiety and depression in cardiac rehabilitation: a single-blind randomized pilot study. Front Psychiatry 2020;11:582 10.3389/fpsyt.2020.0058232714216
  17. Wells A, McNicol K, Reeves D, Salmon P, Davies L, Heagerty A, et al. Improving the effectiveness of psychological interventions for depression and anxiety in the cardiac rehabilitation pathway using group-based metacognitive therapy (PATHWAY Group MCT): study protocol for a randomised controlled trial. Trials 2018;19. 10.1186/s13063-018-2593-8
  18. Wells A, Faija C. Metacognitive therapy for anxiety and depression in cardiac rehabilitation: commentary on the UK National Institute of Health Research funded PATHWAY programme. J Cardiol Cardiovasc Sci 2018;2:10–4. 10.29245/2578-3025/2018/3.1131
  19. Wells A, Reeves D, Capobianco L, Heal C, Davies L, Heagerty A, et al. Improving the effectiveness of psychological interventions for depression and anxiety in cardiac rehabilitation: PATHWAY—a single-blind, parallel, randomized, controlled trial of group metacognitive therapy. Circulation 2021;144:23–33. 10.1161/CIRCULATIONAHA.120.05242834148379
  20. Shields G, Brown L, Wells A, Capobianco L, Vass C. Utilising patient and public involvement in stated preference research in health: learning from the existing literature and a case study. Patient Centered Outcomes Res 2020;14:399–412. 10.1007/s40271-020-00439-2
  21. Shields G, Wells A, Doherty P, Reeves D, Capobianco L, Heagerty A, et al. Protocol for the economic evaluation of metacognitive therapy for cardiac rehabilitation participants with symptoms of anxiety and/or depression. BMJ Open 2020;10:e035552. 10.1136/bmjopen-2019-035552
  22. McPhillips R, Capobianco L, Cooper B, Husain Z, Wells A. Cardiac rehabilitation patients experiences and understanding of group metacognitive therapy: a qualitative study. Open Heart 2021;8:e001708. 10.1136/openhrt-2021-00170834261779
  23. Anderson R, Capobianco L, Fisher P, Reeves D, Heal C, Faija C, et al. Testing relationships between metacognitive beliefs, anxiety, and depression in cardiac and cancer patients: are they transdiagnostic? J Psychosom Res 2019;124:109738. 10.1016/j.jpsychores.2019.10973831443817
  24. Wells A, Reeves D, Heal C, Davies LM, Shields GE, Heagerty A, et al. Evaluating metacognitive therapy to improve treatment of anxiety and depression in cardiovascular disease: the NIHR funded PATHWAY research programme. Front Psychiatry 2022;13:886407. 10.3389/fpsyt.2022.88640735722590
  25. Wells A, Heal C, Reeves D, Capobianco L. Prevalence of post-traumatic stress and tests of metacognition as a PTSD risk marker in patients with coronary heart disease and elevated HADS scores: analysis of data from the PATHWAY RCT’s in UK cardiac rehabilitation. Front Psychiatry 2023;14;1198202. 10.3389/fpsyt.2023.119820237484675
  26. Shields G, Wright S, Wells A, Doherty P, Capobianco L, Davies L. Delivery preferences for psychological intervention in cardiac rehabilitation: a pilot discrete choice experiment. Open Heart 2021;8:e001747. 10.1136/openhrt-2021-00174734426529
  27. Capobianco L, Faija C, Cooper B, Brown L, McPhillips R, Shields G, Wells A. A framework for implementing patient and public involvement in mental health research: the PATHWAY research programme benchmarked against NIHR standards. Health Expect 2023;26:640–50. 10.1111/hex.1367636625226
  28. Wells A, McNicol K, Reeves D, Salmon P, Davies L, Heagerty A, et al. Metacognitive therapy home-based self-help for cardiac rehabilitation patients experiencing anxiety and depressive symptoms: study protocol for a feasibility randomised controlled trial (PATHWAY Home-MCT). Trials 2018;19. 10.1186/s13063-018-2826-x
  29. Wells A, Reeves D, Heal C, Fisher P, Doherty P, Davies L, et al. Metacognitive therapy self-help for anxiety-depression: single-blind randomized feasibility trial in cardiovascular disease. Health Psychol 2022;41:366–77. 10.1037/hea000116835467904
  30. Faija C, Reeves D, Heal C, Capobianco L, Anderson R, Wells A. Measuring the cognitive attentional syndrome in cardiac patients with anxiety and depression symptoms: psychometric properties of the CAS-1R. Front Psychol 2019;10:2109. 10.3389/fpsyg.2019.0210931620051
  31. Faija C, Reeves D, Heal C, Wells A. Metacognition in cardiac patients with anxiety and depression: psychometric performance of the metacognitions questionnaire 30 (MCQ-30). Front Psychol 2020;11:1064. 10.3389/fpsyg.2020.0106432528387
  32. Capobianco L, Faija C, Husain Z, Wells A. Metacognitive beliefs and their relationship with anxiety and depression in physical illnesses: a systematic review. PLOS ONE 2020;15:e0238457. 10.1371/journal.pone.023845732911486
  33. Shields GE, Wells A, Wright S, Vass CM, Doherty PJ, Capobianco L, Davies LM. Discrete choice experiment to investigate preferences for psychological intervention in cardiac rehabilitation. BMJ Open 2022;12:e062503. 10.1136/bmjopen-2022-062503
  34. Wells A, Reeves D, Heal C, Fisher P, Doherty P, Davies L, et al. Metacognitive therapy home-based self-help for anxiety and depression in cardiovascular disease patients in the UK: a single-blind randomised controlled trial. PLOS Med 2023;20:e1004161. 10.1371/journal.pmed.100416136719886
  35. Zigmond A, Snaith R. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–70. 10.1111/j.1600-0447.1983.tb09716.x6880820
  36. DeJean D, Giacomini M, Vanstone M, Brundisini F. Patient experiences of depression and anxiety with chronic disease: a systematic review and qualitative meta-synthesis. Ont Health Technol Assess Ser 2013;13:1–33.
  37. Dekker R. Patient perspectives about depressive symptoms in heart failure. J Cardiovasc Nurs 2014;29:E9–15. 10.1097/jcn.0b013e318273a5d6
  38. Wells A, Matthews G. Attention and Emotion: A Clinical Perspective. Hove: Erlbaum; 1994. 10.1080/02699939408408942
  39. Wells A, Matthews G. Modelling cognition in emotional disorder: the S-REF model. Behav Res Ther 1996;34:881–8. 10.1016/s0005-7967(96)00050-28990539
  40. Wells A. Breaking the cybernetic code: understanding and treating the human metacognitive control system to enhance mental health. Front Psychol 2019;10:2621. 10.3389/fpsyg.2019.0262131920769
  41. McDonald I, Daly J, Jelinek V, Panetta F, Gutman J. Opening Pandora’s box: the unpredictability of reassurance by a normal test result. BMJ 1996;313:329–32. 10.1136/bmj.313.7053.3298760739
  42. Robertson N, Javed N, Samani N, Khunti K. Psychological morbidity, and illness appraisals of patients with cardiac and non-cardiac chest pain attending a rapid access chest pain clinic: a longitudinal cohort study. Heart 2008;94:e12–e12. 10.1136/hrt.2006.10053717540685
  43. Clark A, Barbour R, White M, MacIntyre P. Promoting participation in cardiac rehabilitation: patient choices and experiences. J Adv Nurs 2004;47:5–14. 10.1111/j.1365-2648.2004.03060.x15186462
  44. Jacobson N, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991;59:12–9. 10.1037/0022-006x.59.1.122002127
  45. Curtis L, Burns A. Unit Costs of Health and Social Care 2019. Canterbury: Personal Social Services Research Unit, University of Kent; 2019. URL: www.pssru.ac.uk/project-pages/unit-costs/unit-costs-2019/ (accessed 14 December 2021).
  46. NHS England and NHS Improvement. 2018/19 National Cost Collection Data Publication. London: NHS England and NHS Improvement; 2021. URL: www.england.nhs.uk/publication/2018-19-national-cost-collection-data-publication/ (accessed 14 December 2021).
  47. Lancsar E, Louviere J. Conducting discrete choice experiments to inform healthcare decision making. PharmacoEconomics 2008;26:661–77. 10.2165/00019053-200826080-0000418620460
  48. Whalley B, Thompson D, Taylor R. Psychological interventions for coronary heart disease: Cochrane systematic review and meta-analysis. Int J Behav Med 2012;21:109–21. 10.1007/s12529-012-9282-x
  49. Dickens C, Cherrington A, Adeyemi I, Roughley K, Bower P, Garrett C, et al. Characteristics of psychological interventions that improve depression in people with coronary heart disease. Psychosom Med 2013;75:211–21. 10.1097/psy.0b013e31827ac00923324874
  50. Reavell J, Hopkinson M, Clarkesmith D, Lane D. Effectiveness of cognitive behavioral therapy for depression and anxiety in patients with cardiovascular disease: a systematic review and meta-analysis. Psychosom Med 2018;80:742–53. 10.1097/psy.000000000000062630281027
  51. Reed Johnson F, Lancsar E, Marshall D, Kilambi V, Mühlbacher A, Regier D, et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR conjoint analysis experimental design good research practices task force. Value Health 2013;16:3–13. 10.1016/j.jval.2012.08.222323337210
  52. Choicemetrics. Ngene. 2019. URL: http://www.choice-metrics.com/index.html (accessed 14 December 2021).
  53. Baumeister H, Hutter N, Bengel J. Psychological and pharmacological interventions for depression in patients with coronary artery disease. Cochrane Database Syst Rev 2011;12:CD008012. 10.1002/14651858.CD008012.pub3
  54. Lemay K, Tulloch H, Pipe A, Reed J. Establishing the minimal clinically important difference for the hospital anxiety and depression scale in patients with cardiovascular disease. J Cardiopulm Rehabil Prev 2019;39:E6–11. 10.1097/HCR.000000000000037930489438
  55. Schweikert B, Hahmann H, Leidl R. Validation of the EuroQol questionnaire in cardiac rehabilitation. Heart 2006;92:62–7. 10.1136/hrt.2004.05278715797936
  56. National Institute for Health and Care Excellence (NICE). Guide to the Methods of Technology Appraisal 2013. London: NICE; 2013. URL: www.nice.org.uk/process/pmg9/chapter/foreword (accessed 14 December 2021).
  57. Van Hout B, Janssen M, Feng Y, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health 2012;15:708–15. 10.1016/j.jval.2012.02.00822867780
  58. McCabe C, Claxton K, Culyer A. The NICE cost-effectiveness threshold. PharmacoEconomics 2008;26:733–44. 10.2165/00019053-200826090-0000418767894
  59. Bertelsen J, Dehbarez N, Refsgaard J, Kanstrup H, Johnsen S, Qvist I, et al Shared care versus hospital-based cardiac rehabilitation: a cost-utility analysis based on a randomised controlled trial. Open Heart 2018;5:e000584. 10.1136/openhrt-2016-00058429531754
  60. Hwang R, Morris N, Mandrusiak A, Bruning J, Peters R, Korczyk D, et al. Cost-utility analysis of home-based telerehabilitation compared with centre-based rehabilitation in patients with heart failure. Heart Lung Circ 2019;28:1795–803. 10.1016/j.hlc.2018.11.01030528811
  61. Taylor R, Sadler S, Dalal H, Warren F, Jolly K, Davis R, et al. The cost effectiveness of REACH-HF and home-based cardiac rehabilitation compared with the usual medical care for heart failure with reduced ejection fraction: a decision model-based analysis. Eur J Prev Cardiol 2019;26:1252–61. 10.1177/204748731983350730884975
  62. Leggett L, Khadaroo R, Holroyd-Leduc J, Lorenzetti D, Hanson H, Wagg A, et al. Measuring resource utilization. Medicine 2016;95:e2759. 10.1097/MD.0000000000002726962773
  63. NHS England and NHS Improvement. 2017/18 National Cost Collection Data Publication. 2018. URL: webarchive.nationalarchives.gov.uk/ukgwa/20200501111106/https://improvement.nhs.uk/resources/reference-costs/ (accessed 14 December 2021).
← General discussionAdditional information →

Attribution. Adrian Wells; David Reeves; Peter Fisher; Linda Davies; Gemma Shields; Patrick Joseph Doherty et al. (2024). Improving the Effectiveness of Psychological Interventions for Depression and Anxiety in Cardiac Rehabilitation: The PATHWAY Research Programme Including 4 RCTs. National Institute for Health and Care Research. Copyright © 2024 Wells et al. Licensed under CC BY 4.0. NCBI Bookshelf NBK607676. CC BY 4.0. Original source ↗. Text reproduced from the Bookshelf XML without changing wording; figures, images and supplements are not reproduced.

In this chapter Contents

  • References

Source

OpenStax source file ↗

Source record ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support